Search research articles
Contact Us
Filters
Showing results (281-290 of 481) with videos related to
Page
of 49
Sort By:
The Lancet. Gastroenterology & Hepatology
|
April 22, 2023
Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis
Yunhao Li, Horace Choi, Kathy Leung, et al.
Gut
|
September 5, 2015
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy
Wei Zhang, Qi Chen, Xiao Liang, et al.
Gastrointestinal Endoscopy
|
April 20, 2010
Biliary stenting in the management of large or multiple common bile duct stones
Akira Horiuchi, Yoshiko Nakayama, Masashi Kajiyama, et al.
Journal of Proteomics & Bioinformatics
|
August 19, 2014
Diagnostics for Statistical Variable Selection Methods for Prediction of Peptic Ulcer Disease in <i>Helicobacter pylori</i> Infection
Hyunsu Ju, Allan R Brasier, Alexander Kurosky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2002
Risk Factors Associated with Helicobacter pylori Infection among Children in a Defined Geographic Area
Maria P Dore, Hoda M Malaty, David Y Graham, et al.
Helicobacter
|
September 14, 2004
Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads
Ratha-Korn Vilaichone, Varocha Mahachai, Somying Tumwasorn, et al.
Digestion
|
August 22, 2012
In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine
Yun Jeong Lim, Tri M Phan, Elizabeth J Dial, et al.
Scandinavian Journal of Gastroenterology
|
July 23, 2005
Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype
Ratha-Korn Vilaichone, Varocha Mahachai, Somying Tumwasorn, et al.
Digestive Diseases and Sciences
|
February 6, 2020
14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment
Laisheng Luo, Yingjie Ji, Lou Yu, et al.
Helicobacter
|
August 3, 2006
A prospective study for the association of Helicobacter pylori infection to a multidimensional measure for recurrent abdominal pain in children
Hoda M Malaty, Suhaib Abudayyeh, David Y Graham, et al.
Page
of 49
Search research articles
Search
Showing results (281-290 of 481) with videos related to
Sort By:
Page
of 49
The Lancet. Gastroenterology & Hepatology
|
April 22, 2023
Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis
Yunhao Li, Horace Choi, Kathy Leung, et al.
Gut
|
September 5, 2015
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy
Wei Zhang, Qi Chen, Xiao Liang, et al.
Gastrointestinal Endoscopy
|
April 20, 2010
Biliary stenting in the management of large or multiple common bile duct stones
Akira Horiuchi, Yoshiko Nakayama, Masashi Kajiyama, et al.
Journal of Proteomics & Bioinformatics
|
August 19, 2014
Diagnostics for Statistical Variable Selection Methods for Prediction of Peptic Ulcer Disease in <i>Helicobacter pylori</i> Infection
Hyunsu Ju, Allan R Brasier, Alexander Kurosky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2002
Risk Factors Associated with Helicobacter pylori Infection among Children in a Defined Geographic Area
Maria P Dore, Hoda M Malaty, David Y Graham, et al.
Helicobacter
|
September 14, 2004
Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads
Ratha-Korn Vilaichone, Varocha Mahachai, Somying Tumwasorn, et al.
Digestion
|
August 22, 2012
In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine
Yun Jeong Lim, Tri M Phan, Elizabeth J Dial, et al.
Scandinavian Journal of Gastroenterology
|
July 23, 2005
Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype
Ratha-Korn Vilaichone, Varocha Mahachai, Somying Tumwasorn, et al.
Digestive Diseases and Sciences
|
February 6, 2020
14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment
Laisheng Luo, Yingjie Ji, Lou Yu, et al.
Helicobacter
|
August 3, 2006
A prospective study for the association of Helicobacter pylori infection to a multidimensional measure for recurrent abdominal pain in children
Hoda M Malaty, Suhaib Abudayyeh, David Y Graham, et al.
Page
of 49